ID   REST_RAT                Reviewed;        1069 AA.
AC   O54963; O54964;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   02-OCT-2024, entry version 159.
DE   RecName: Full=RE1-silencing transcription factor;
DE   AltName: Full=Neural-restrictive silencer factor;
GN   Name=Rest; Synonyms=Nrsf;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6 AND 7), FUNCTION,
RP   TISSUE SPECIFICITY, INDUCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=9454838; DOI=10.1523/jneurosci.18-04-01280.1998;
RA   Palm K., Belluardo N., Metsis M., Timmusk T.;
RT   "Neuronal expression of zinc finger transcription factor REST/NRSF/XBR
RT   gene.";
RL   J. Neurosci. 18:1280-1296(1998).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10490617; DOI=10.1128/mcb.19.10.6788;
RA   Shimojo M., Paquette A.J., Anderson D.J., Hersh L.B.;
RT   "Protein kinase A regulates cholinergic gene expression in PC12 cells:
RT   REST4 silences the silencing activity of neuron-restrictive silencer
RT   factor/REST.";
RL   Mol. Cell. Biol. 19:6788-6795(1999).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION BY
RP   ISCHEMIA.
RX   PubMed=12657670; DOI=10.1523/jneurosci.23-06-02112.2003;
RA   Calderone A., Jover T., Noh K.M., Tanaka H., Yokota H., Lin Y.,
RA   Grooms S.Y., Regis R., Bennett M.V., Zukin R.S.;
RT   "Ischemic insults derepress the gene silencer REST in neurons destined to
RT   die.";
RL   J. Neurosci. 23:2112-2121(2003).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-948, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   AND INDUCTION.
RX   PubMed=22960932; DOI=10.1038/nn.3214;
RA   Rodenas-Ruano A., Chavez A.E., Cossio M.J., Castillo P.E., Zukin R.S.;
RT   "REST-dependent epigenetic remodeling promotes the developmental switch in
RT   synaptic NMDA receptors.";
RL   Nat. Neurosci. 15:1382-1390(2012).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION BY
RP   ISCHEMIA.
RX   PubMed=22371606; DOI=10.1073/pnas.1121568109;
RA   Noh K.M., Hwang J.Y., Follenzi A., Athanasiadou R., Miyawaki T.,
RA   Greally J.M., Bennett M.V., Zukin R.S.;
RT   "Repressor element-1 silencing transcription factor (REST)-dependent
RT   epigenetic remodeling is critical to ischemia-induced neuronal death.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:E962-E971(2012).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION BY ISCHEMIA.
RX   PubMed=25108103; DOI=10.1016/j.jmb.2014.07.032;
RA   Hwang J.Y., Kaneko N., Noh K.M., Pontarelli F., Zukin R.S.;
RT   "The gene silencing transcription factor REST represses miR-132 expression
RT   in hippocampal neurons destined to die.";
RL   J. Mol. Biol. 426:3454-3466(2014).
CC   -!- FUNCTION: Transcriptional repressor which binds neuron-restrictive
CC       silencer element (NRSE) and represses neuronal gene transcription in
CC       non-neuronal cells (By similarity). Restricts the expression of
CC       neuronal genes by associating with two distinct corepressors, SIN3A and
CC       RCOR1, which in turn recruit histone deacetylase to the promoters of
CC       REST-regulated genes (By similarity). Mediates repression by recruiting
CC       the BHC complex at RE1/NRSE sites which acts by deacetylating and
CC       demethylating specific sites on histones, thereby acting as a chromatin
CC       modifier (PubMed:9454838). Transcriptional repression by REST-CDYL via
CC       the recruitment of histone methyltransferase EHMT2 may be important in
CC       transformation suppression (By similarity). Represses the expression of
CC       SRRM4 in non-neural cells to prevent the activation of neural-specific
CC       splicing events and to prevent production of REST isoform 6 (By
CC       similarity). Repressor activity may be inhibited by forming
CC       heterodimers with isoform 6, thereby preventing binding to NRSE or
CC       binding to corepressors and leading to derepression of target genes (By
CC       similarity). Also maintains repression of neuronal genes in neural stem
CC       cells, and allows transcription and differentiation into neurons by
CC       dissociation from RE1/NRSE sites of target genes (By similarity).
CC       Thereby is involved in maintaining the quiescent state of adult
CC       hippocampal neural stem cells and preventing premature differentiation
CC       into mature neurons (By similarity). Plays a role in the developmental
CC       switch in synaptic NMDA receptor composition during postnatal
CC       development, by repressing GRIN2B expression and thereby altering NMDA
CC       receptor properties from containing primarily GRIN2B to primarily
CC       GRIN2A subunits (PubMed:22960932). Acts as a regulator of osteoblast
CC       differentiation (By similarity). Key repressor of gene expression in
CC       hypoxia; represses genes in hypoxia by direct binding to an RE1/NRSE
CC       site on their promoter regions (By similarity). May also function in
CC       stress resistance in the brain during aging; possibly by regulating
CC       expression of genes involved in cell death and in the stress response
CC       (By similarity). Repressor of gene expression in the hippocampus after
CC       ischemia by directly binding to RE1/NRSE sites and recruiting SIN3A and
CC       RCOR1 to promoters of target genes, thereby promoting changes in
CC       chromatin modifications and ischemia-induced cell death
CC       (PubMed:12657670, PubMed:22371606). After ischemia, might play a role
CC       in repression of miR-132 expression in hippocampal neurons, thereby
CC       leading to neuronal cell death (PubMed:25108103).
CC       {ECO:0000250|UniProtKB:Q13127, ECO:0000250|UniProtKB:Q8VIG1,
CC       ECO:0000269|PubMed:12657670, ECO:0000269|PubMed:22371606,
CC       ECO:0000269|PubMed:22960932, ECO:0000269|PubMed:25108103,
CC       ECO:0000269|PubMed:9454838}.
CC   -!- FUNCTION: [Isoform 6]: Binds to the 3' region of the neuron-restrictive
CC       silencer element (NRSE), with lower affinity than full-length REST
CC       isoform 1 (By similarity). Exhibits weaker repressor activity compared
CC       to isoform 1 (By similarity). May negatively regulate the repressor
CC       activity of isoform 1 by binding to isoform 1, thereby preventing its
CC       binding to NRSE and leading to derepression of target genes (By
CC       similarity). However, in another study, does not appear to be
CC       implicated in repressor activity of a NRSE motif-containing reporter
CC       construct nor in inhibitory activity on the isoform 1 transcriptional
CC       repressor activity (By similarity). Post-transcriptional inactivation
CC       of REST by SRRM4-dependent alternative splicing into isoform 6 is
CC       required in mechanosensory hair cells in the inner ear for derepression
CC       of neuronal genes and hearing (By similarity).
CC       {ECO:0000250|UniProtKB:Q13127, ECO:0000250|UniProtKB:Q8VIG1}.
CC   -!- SUBUNIT: Isoform 1 and isoform 6 form heterodimers (By similarity).
CC       Isoform 6: Forms homodimers and homooligomers; binds to the neuron-
CC       restrictive silencer element (NRSE) as monomer (By similarity).
CC       Interacts with SIN3A, SIN3B and RCOR1 (By similarity). Interacts with
CC       CDYL (By similarity). Interacts with EHMT1 and EHMT2 only in the
CC       presence of CDYL (By similarity). Part of a complex containing at least
CC       CDYL, REST, WIZ, SETB1, EHMT1 and EHMT2 (By similarity). Interacts (via
CC       zinc-finger DNA-binding domain) with ZFP90 (via N- and C-termini); the
CC       interaction inhibits REST repressor activity (By similarity). Interacts
CC       (via C2H2-type zinc finger 5) with PRICKLE1 (By similarity). Interacts
CC       with FBXW11 and BTRC (By similarity). Interacts with USP7 (By
CC       similarity). {ECO:0000250|UniProtKB:Q13127,
CC       ECO:0000250|UniProtKB:Q8VIG1}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10490617,
CC       ECO:0000269|PubMed:12657670, ECO:0000269|PubMed:22371606,
CC       ECO:0000269|PubMed:22960932}. Cytoplasm {ECO:0000250|UniProtKB:Q13127}.
CC       Note=Colocalizes with ZFP90 in the nucleus (By similarity). In response
CC       to hypoxia, there is a more pronounced increase in levels in the
CC       nucleus as compared to the cytoplasm (By similarity). In aging neurons,
CC       increased levels in the nucleus as compared to the cytoplasm (By
CC       similarity). {ECO:0000250|UniProtKB:Q13127,
CC       ECO:0000250|UniProtKB:Q8VIG1}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 6]: Nucleus
CC       {ECO:0000250|UniProtKB:Q13127}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=O54963-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O54963-2; Sequence=VSP_022074, VSP_022075;
CC       Name=3; Synonyms=REST1;
CC         IsoId=O54963-3; Sequence=VSP_022073;
CC       Name=4; Synonyms=REST2;
CC         IsoId=O54963-4; Sequence=VSP_022079, VSP_022080;
CC       Name=5; Synonyms=REST3;
CC         IsoId=O54963-5; Sequence=VSP_022078, VSP_022081;
CC       Name=6; Synonyms=REST4;
CC         IsoId=O54963-6; Sequence=VSP_022077, VSP_022082;
CC       Name=7; Synonyms=REST5;
CC         IsoId=O54963-7; Sequence=VSP_022076, VSP_022083;
CC   -!- TISSUE SPECIFICITY: Expressed in the hippocampus including the granule
CC       cell layer of the dentate gyrus, the pyramidal cell layers of CA1 and
CC       CA3, the apical and basilar dendrite layers of the stratum radiatum and
CC       stratum oriens of CA1, the stratum lucidum and stratum oriens of CA3
CC       and in astroglia (at protein level) (PubMed:12657670, PubMed:22371606,
CC       PubMed:22960932). Expressed in the brain, with the highest levels in
CC       the neurons of hippocampus, pons/medulla and midbrain (PubMed:25108103,
CC       PubMed:9454838). {ECO:0000269|PubMed:12657670,
CC       ECO:0000269|PubMed:22371606, ECO:0000269|PubMed:22960932,
CC       ECO:0000269|PubMed:25108103, ECO:0000269|PubMed:9454838}.
CC   -!- DEVELOPMENTAL STAGE: Levels decrease during embryonic brain development
CC       (PubMed:9454838). Expressed during postnatal days P3 to P60, with an
CC       increase in expression at postnatal day P14-P15 (PubMed:22960932).
CC       Increased abundance in the nucleus at P14-P15 relative to P9
CC       (PubMed:22960932). {ECO:0000269|PubMed:22960932,
CC       ECO:0000269|PubMed:9454838}.
CC   -!- INDUCTION: Up-regulated by kainic acid (PubMed:9454838). Up-regulated
CC       in the pyramidal cell layer of CA1 in the hippocampus by global
CC       ischemia (PubMed:12657670, PubMed:22371606, PubMed:25108103). Down-
CC       regulated in the hippocampus by maternal deprivation (PubMed:22960932).
CC       {ECO:0000269|PubMed:12657670, ECO:0000269|PubMed:22371606,
CC       ECO:0000269|PubMed:22960932, ECO:0000269|PubMed:25108103,
CC       ECO:0000269|PubMed:9454838}.
CC   -!- DOMAIN: The C2H2-type zinc finger 5 is required for nuclear
CC       localization. {ECO:0000250|UniProtKB:Q13127}.
CC   -!- PTM: O-glycosylated. {ECO:0000250|UniProtKB:Q8VIG1}.
CC   -!- PTM: Phosphorylated; phosphorylation is required for ubiquitination.
CC       {ECO:0000250|UniProtKB:Q13127}.
CC   -!- PTM: Ubiquitinated; ubiquitination is mediated by BTRC and leads to
CC       proteasomal degradation in G2 phase (By similarity). Ubiquitination
CC       increases during neuronal differentiation (By similarity).
CC       Deubiquitinated by USP7; leading to its stabilization and promoting the
CC       maintenance of neural progenitor cells (By similarity).
CC       {ECO:0000250|UniProtKB:Q13127}.
CC   -!- MISCELLANEOUS: [Isoform 6]: Produced by SRRM4-dependent alternative
CC       splicing in neurons and inner ear hair cells (By similarity). Lacks the
CC       four C-terminal zinc fingers and the RCOR1 corepressor interaction site
CC       found in full length REST isoform 1, which are required for full DNA-
CC       binding and repressive activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q8VIG1}.
CC   -!- CAUTION: Isoform 6: Controversial data exists concerning the repressor
CC       activity of isoform 6. In human, a study showed that human isoform 3
CC       exhibits weak repressor activity of a NRSE motif-containing reporter
CC       construct (By similarity). Another report, however, does not observe
CC       any isoform 3 repressor activity of a NRSE motif-containing reporter
CC       construct (By similarity). Isoform 6: Controversial data also exists
CC       regarding the function of isoform 6 on the negative regulation of
CC       isoform 1. In mouse, it was shown that isoform 2 negatively regulates
CC       the repressor activity of isoform 1 by binding to isoform 1, thereby
CC       preventing its binding to NRSE and leading to derepression of target
CC       genes (By similarity). Another study in human, however, did not observe
CC       any inhibitory activity of human isoform 3 on the isoform 1
CC       transcriptional repressor activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q13127, ECO:0000250|UniProtKB:Q8VIG1}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF037199; AAB94893.1; -; mRNA.
DR   EMBL; AF037203; AAB94894.1; -; mRNA.
DR   RefSeq; NP_113976.1; NM_031788.1.
DR   AlphaFoldDB; O54963; -.
DR   BMRB; O54963; -.
DR   SMR; O54963; -.
DR   BioGRID; 249783; 2.
DR   STRING; 10116.ENSRNOP00000002844; -.
DR   CarbonylDB; O54963; -.
DR   iPTMnet; O54963; -.
DR   PhosphoSitePlus; O54963; -.
DR   PaxDb; 10116-ENSRNOP00000002837; -.
DR   GeneID; 83618; -.
DR   KEGG; rno:83618; -.
DR   UCSC; RGD:621069; rat. [O54963-1]
DR   AGR; RGD:621069; -.
DR   CTD; 5978; -.
DR   RGD; 621069; Rest.
DR   eggNOG; KOG1721; Eukaryota.
DR   InParanoid; O54963; -.
DR   OrthoDB; 4169790at2759; -.
DR   PhylomeDB; O54963; -.
DR   Reactome; R-RNO-3214815; HDACs deacetylate histones.
DR   PRO; PR:O54963; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0017053; C:transcription repressor complex; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISS:UniProtKB.
DR   GO; GO:0060088; P:auditory receptor cell stereocilium organization; ISS:UniProtKB.
DR   GO; GO:0060379; P:cardiac muscle cell myoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0071257; P:cellular response to electrical stimulus; ISS:UniProtKB.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; ISS:UniProtKB.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISS:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; IMP:UniProtKB.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISS:UniProtKB.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0099563; P:modification of synaptic structure; IMP:UniProtKB.
DR   GO; GO:0043922; P:negative regulation by host of viral transcription; ISS:UniProtKB.
DR   GO; GO:0032348; P:negative regulation of aldosterone biosynthetic process; IMP:UniProtKB.
DR   GO; GO:2000798; P:negative regulation of amniotic stem cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:2000065; P:negative regulation of cortisol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:2000706; P:negative regulation of dense core granule biogenesis; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:2000740; P:negative regulation of mesenchymal stem cell differentiation; ISO:RGD.
DR   GO; GO:1902894; P:negative regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; ISS:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:2000678; P:negative regulation of transcription regulatory region DNA binding; ISS:UniProtKB.
DR   GO; GO:0050877; P:nervous system process; ISS:UniProtKB.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; IEP:RGD.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; IMP:UniProtKB.
DR   GO; GO:1902459; P:positive regulation of stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0002931; P:response to ischemia; IDA:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISS:UniProtKB.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 5.
DR   InterPro; IPR050688; Zinc_finger/UBP_domain.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24403:SF102; RE1-SILENCING TRANSCRIPTION FACTOR; 1.
DR   PANTHER; PTHR24403; ZINC FINGER PROTEIN; 1.
DR   Pfam; PF00096; zf-C2H2; 1.
DR   SMART; SM00355; ZnF_C2H2; 9.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1069
FT                   /note="RE1-silencing transcription factor"
FT                   /id="PRO_0000269549"
FT   ZN_FING         158..180
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         215..237
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         247..269
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         275..297
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         303..325
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         331..354
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         360..382
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         388..411
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         1032..1054
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          32..121
FT                   /note="Interaction with SIN3A"
FT                   /evidence="ECO:0000250|UniProtKB:Q13127"
FT   REGION          43..57
FT                   /note="Interaction with SIN3B"
FT                   /evidence="ECO:0000250|UniProtKB:Q13127"
FT   REGION          85..104
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          144..417
FT                   /note="Interaction with ZFP90"
FT                   /evidence="ECO:0000250|UniProtKB:Q13127"
FT   REGION          200..211
FT                   /note="Required for binding to the neuron-restrictive
FT                   silencer element"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIG1"
FT   REGION          425..737
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          830..1022
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          981..1059
FT                   /note="Interaction with RCOR1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13127"
FT   COMPBIAS        86..100
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        425..444
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        452..481
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        521..537
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        545..582
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        628..666
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        667..737
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        847..864
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        893..918
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        926..940
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        977..993
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         948
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         300..1069
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022073"
FT   VAR_SEQ         300..302
FT                   /note="ERP -> KRA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022074"
FT   VAR_SEQ         303..1069
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022075"
FT   VAR_SEQ         328..336
FT                   /note="EKPFKCDQC -> CDLVGYVFR (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022076"
FT   VAR_SEQ         328..332
FT                   /note="EKPFK -> CDLVG (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022077"
FT   VAR_SEQ         328..329
FT                   /note="EK -> AI (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022078"
FT   VAR_SEQ         328
FT                   /note="E -> W (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022079"
FT   VAR_SEQ         329..1069
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022080"
FT   VAR_SEQ         330..1069
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022081"
FT   VAR_SEQ         333..1069
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022082"
FT   VAR_SEQ         337..1069
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:9454838"
FT                   /id="VSP_022083"
SQ   SEQUENCE   1069 AA;  117126 MW;  0A040248D8526992 CRC64;
     MATQVMGQSS GGGSLFNNSG NMGMALPNDM YDLHDLSKAE LAAPQLIMLA NVALTGEVNG
     SCCDYLVGEE RQMAELMPVG DNHFSDSEGE GLEESAELKG DPSGLDNMEL RSLELSVVEP
     QPVFEASAAP EVYSSNKDPA PEAPVAEDKC KNLKAKPFRC KPCQYEAESE EQFVHHIRVH
     SAKKFFVEES AEKQAKARES GASPSEEGEF SKGPIRCDRC GYNTNRYDHY TAHLKHHLRA
     GDNERVYKCI ICTYTTVSEY HWRKHLRNHF PRKVYTCSKC NYFSTEKNNY VQHVRTHTGE
     RPYKCELCPY SSSQKTHLTR HMRTHSGEKP FKCDQCNYVA SNQHEVTRHA RQVHNGPKPL
     NCPHCDYKTA DRSNFKKHVE LHVNPRQFNC PVCDYAASKK CNLQYHFKSK HPTCPSKTMD
     VSKVKLKKTK RREADLHRDA AAAATEQTDT EQAKTKGVDA SARRSERPVK GVGKDVPKEK
     KPCSNASVVQ VTTRTRKSAV ETKAAEGKHT DGQTGNNAEK SSKAKKSKRK MDAEAHPSVE
     PVTEGPVTKK KKTESKPKTS GEVPKGSRVE DRKADKQQSA SIKKGGKKTA LKTKTAKKGS
     KLAPKWVGHT EPSSEMAQGG ESPVPALTQA VVTPSGSTQT ELSSPMDIAQ TEPAQMDVSQ
     TGPPQVQRPL PVEPAQLEPS PPQEPPQVEP PACVEPPPPV EPPCPMEPAE MEPSPPMEPS
     QVEPPPHLEP PLPMELPQVE LPPVEDCQKE LPPVEHAQTK VAQTGPTQVG AVQEEPLFCL
     RATSSQANQK VISPKDRAKE KLSVLSEMAR QEQVLIEVGL VPVRDSQLLK ASKSAPDLPA
     PPSPLPKGHL RREETPKDQE MFSDGEGNKV SPLEKGGTEE AGESRAELAA PMESTSALSS
     EQSSNAPDGE TLHSECQADS TAVCEMEVDT EQKTDRVPLK DSAVEPVSPL NPRVDPEAAA
     PAVVASPPIT LAESQEIDED EGIHSHDGSD LSDNMSEGSD DSGLHGARPA PQEATSKSGK
     EGLAVKVTEG EFVCIFCDRS FRKEKDYSKH LNRHLVNVYF LEEAAEEQE
//
